HAI TSAO: Open Payments
NPI 1447226527 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 11 payments from 6 companies in 2025. Trend: 2023 $212 · 2024 $133 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $16 |
Products named: ABILIFY ASIMTUFII, INVEGA SUSTENNA, UZEDY, COBENFY, INGREZZA, AUSTEDO XR, VRAYLAR.
Industry payments across PA — which companies pay providers there.
